KalVista Pharmaceuticals (KALV) Other Gross PP&E Adjustments (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly Other Gross PP&E Adjustments of -$10.0 million in Q3 2025, down 221.0% quarter-over-quarter from -$3.1 million in Q2 2025, and down 7.07% year-over-year from -$10.8 million in Q3 2024.
KalVista Pharmaceuticals' Other Gross PP&E Adjustments history runs 12 years deep, the most recent figure standing at -$10.0 million for Q3 2025.
- In Q3 2025, Other Gross PP&E Adjustments fell 7.07% year-over-year to -$10.0 million; the TTM figure through Jul 2025 stood at -$10.0 million (down 7.07% YoY), while the FY2025 annual figure was -$3.1 million, up 33.38% from the prior year.
- Other Gross PP&E Adjustments came in at -$10.0 million for Q3 2025 at KalVista Pharmaceuticals, down from -$3.1 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$1.9 million in Q1 2021 to a low of -$10.0 million in Q3 2025.
- A 5-year average of -$7.3 million and a median of -$8.8 million in 2022 frame the typical range for Other Gross PP&E Adjustments.
- Across the five-year window, Other Gross PP&E Adjustments tumbled 370.2% in 2021 and soared 33.38% in 2025, its largest moves.
- KalVista Pharmaceuticals' Other Gross PP&E Adjustments stood at -$7.6 million in 2021, then dropped by 23.7% to -$9.4 million in 2022, then advanced by 4.11% to -$9.0 million in 2023, then decreased by 5.25% to -$9.5 million in 2024, then fell by 5.58% to -$10.0 million in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered -$10.0 million, -$3.1 million, and -$9.5 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | -10.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -10.03 Mn |
| Jul 31, 2025 | -10.03 Mn |
| Apr 30, 2025 | -3.12 Mn |
| Apr 30, 2025 | -3.12 Mn |
| Dec 31, 2024 | -9.50 Mn |
| Dec 31, 2024 | -9.50 Mn |
| Oct 31, 2024 | -9.79 Mn |
| Oct 31, 2024 | -9.79 Mn |
| Jul 31, 2024 | -9.37 Mn |
| Jul 31, 2024 | -9.37 Mn |
| Apr 30, 2024 | -4.69 Mn |
| Apr 30, 2024 | -4.69 Mn |
| Jan 31, 2024 | -8.29 Mn |
| Jan 31, 2024 | -8.29 Mn |
| Oct 31, 2023 | -9.02 Mn |
| Oct 31, 2023 | -9.02 Mn |
| Jul 31, 2023 | -8.95 Mn |
| Jul 31, 2023 | -8.95 Mn |
| Apr 30, 2023 | -5.83 Mn |
| Apr 30, 2023 | -5.83 Mn |
| Jan 31, 2023 | -9.22 Mn |
| Jan 31, 2023 | -9.22 Mn |
| Oct 31, 2022 | -9.41 Mn |
| Oct 31, 2022 | -9.41 Mn |
| Jul 31, 2022 | -9.71 Mn |
| Jul 31, 2022 | -9.71 Mn |
| Apr 30, 2022 | -3.74 Mn |
| Apr 30, 2022 | -3.74 Mn |
| Jan 31, 2022 | -8.78 Mn |
| Jan 31, 2022 | -8.78 Mn |
| Oct 31, 2021 | -7.61 Mn |
| Oct 31, 2021 | -7.61 Mn |
| Jul 31, 2021 | -7.94 Mn |
| Jul 31, 2021 | -7.94 Mn |
| Apr 30, 2021 | -2.44 Mn |
| Apr 30, 2021 | -2.44 Mn |
| Jan 31, 2021 | -1.90 Mn |
| Jan 31, 2021 | -1.90 Mn |
| Oct 31, 2020 | -1.72 Mn |
| Oct 31, 2020 | -1.72 Mn |
| Jul 31, 2020 | -1.69 Mn |
| Jul 31, 2020 | -1.69 Mn |
| Apr 30, 2020 | 1.63 Mn |
| Apr 30, 2020 | 1.63 Mn |
| Jan 31, 2020 | -1.70 Mn |
| Jan 31, 2020 | -1.70 Mn |
| Oct 31, 2019 | -2.02 Mn |
| Oct 31, 2019 | -2.02 Mn |
| Jul 31, 2019 | -1.91 Mn |
| Jul 31, 2019 | -1.91 Mn |
| Apr 30, 2019 | 2.62 Mn |
| Apr 30, 2019 | 2.62 Mn |
| Jan 31, 2019 | -86,000.00 |
| Jan 31, 2019 | -86,000.00 |
| Oct 31, 2018 | -122,000.00 |
| Oct 31, 2018 | -122,000.00 |
| Jul 31, 2018 | -291,000.00 |
| Jul 31, 2018 | -291,000.00 |
| Apr 30, 2018 | 2.23 Mn |
| Apr 30, 2018 | 2.23 Mn |
| Jan 31, 2018 | -233,000.00 |
| Jan 31, 2018 | -233,000.00 |
| Oct 31, 2017 | -309,000.00 |
| Oct 31, 2017 | -309,000.00 |
| Jul 31, 2017 | -423,000.00 |
| Jul 31, 2017 | -423,000.00 |
| Apr 30, 2017 | 264,000.00 |
| Apr 30, 2017 | 264,000.00 |
| Mar 31, 2016 | 375,000.00 |
| Mar 31, 2016 | 375,000.00 |
| Dec 31, 2015 | 1.25 Mn |
| Dec 31, 2015 | 1.25 Mn |
| Sep 30, 2015 | 955,000.00 |
| Sep 30, 2015 | 955,000.00 |
| Jun 30, 2015 | 934,000.00 |
| Jun 30, 2015 | 934,000.00 |
| Mar 31, 2015 | 855,000.00 |
| Mar 31, 2015 | 855,000.00 |
| Dec 31, 2014 | 616,000.00 |
| Dec 31, 2014 | 616,000.00 |